Chemoinformaics analysis of trans-dehydromatricaria ester
Molecular Weight | 172.183 | nRot | 1 |
Heavy Atom Molecular Weight | 164.119 | nRig | 5 |
Exact Molecular Weight | 172.052 | nRing | 0 |
Solubility: LogS | -3.206 | nHRing | 0 |
Solubility: LogP | 2.959 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 25.3083 |
nHD | 0 | BPOL | 10.6297 |
QED | 0.331 |
Synth | 3.677 |
Natural Product Likeliness | 2.654 |
NR-PPAR-gamma | 0.871 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.03 |
Pgp-sub | 0 |
HIA | 0.79 |
CACO-2 | -4.301 |
MDCK | 0.0000705 |
BBB | 0.004 |
PPB | 1.01621 |
VDSS | 0.982 |
FU | 0.0313808 |
CYP1A2-inh | 0.979 |
CYP1A2-sub | 0.535 |
CYP2c19-inh | 0.922 |
CYP2c19-sub | 0.708 |
CYP2c9-inh | 0.902 |
CYP2c9-sub | 0.657 |
CYP2d6-inh | 0.719 |
CYP2d6-sub | 0.201 |
CYP3a4-inh | 0.813 |
CYP3a4-sub | 0.217 |
CL | 8.372 |
T12 | 0.534 |
hERG | 0.003 |
Ames | 0.69 |
ROA | 0.936 |
SkinSen | 0.968 |
Carcinogencity | 0.56 |
EI | 0.96 |
Respiratory | 0.857 |
NR-Aromatase | 0.896 |
Antiviral | No |
Prediction | 0.737821 |